Tenax Therapeutics, Inc. Profile Avatar - Palmy Investing

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that …

Biotechnology
US, Morrisville [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of TENX's Analysis
CIK: 34956 CUSIP: 88032L209 ISIN: US88032L6056 LEI: - UEI: -
Secondary Listings
TENX has no secondary listings inside our databases.